An overview of AI’s history, opportunities and challenges, with the latest clinical trials and regulatory news  

Setting the stage for the immense amount of discussion and insights on artificial intelligence (AI) during the 109th Radiological Society of North America Scientific Sessions and Annual Meeting (RSNA23), one of the first sessions  brought high-level human intelligence to a crowded room of attendees, including myself, eager to learn the latest. 

Playing sports is good for all ages: it helps participants stay in shape, learn how to organize their time, and help build relationships with peers. However, sports can be dangerous. In fact, a 2023 study found that approximately 5.2 million sports injuries occurred in high school athletes in the US. *

January 15, 2024 — MRI simulation software leader ScanLabMR announced the release of UltraLab, a breakthrough software feature that combines two previously separated concepts: image contrast and spatial resolution, into one interface. The UltraLab interface also brings together radiofrequency (RF) and scan time elements within Gradient Echo, Spin Echo and Fast Spin echo pulse sequences.

January 15, 2024 — After fulfilling all regulatory requirements, the KA Imaging Premium Dual-Energy Mobile System, Reveal Mobi Pro, is now available for sale in the United States. This product is a collaboration with UMG/Del Medical.

AI is reshaping healthcare practice through innovative tools and technologies that augment the capabilities of healthcare providers while streamlining workflows and enhancing diagnostic accuracy

Various definitions for artificial intelligence (AI) have emerged as the technology has evolved.
Artificial intelligence in oncology uses deep learning algorithms to analyze medical images and genomic data to detect cancer at an early stage, predict patient outcomes, and personalize treatment plans. It helps radiologists in diagnosing cancer accurately by analyzing medical images.

Coherent Market Insights has recently published a report, titled, 

January 12, 2024 — RefleXion Medical, Inc., a therapeutic oncology company, announced that the Centers for Medicare and Medicaid Services (CMS) has established a national payment rate for RefleXion’s 

January 12, 2024 — NeuroLogica Corp. announced its OmniTom Elite PCD has received an Innovative Technology designation from 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now